908 Devices (NASDAQ:MASS – Get Rating) is one of 28 publicly-traded companies in the “Measuring & controlling devices, not elsewhere classified” industry, but how does it compare to its rivals? We will compare 908 Devices to similar companies based on the strength of its dividends, earnings, analyst recommendations, institutional ownership, valuation, risk and profitability.
Analyst Ratings
This is a summary of recent recommendations and price targets for 908 Devices and its rivals, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| 908 Devices | 0 | 0 | 1 | 0 | 3.00 |
| 908 Devices Competitors | 154 | 685 | 951 | 28 | 2.47 |
908 Devices currently has a consensus target price of $30.00, indicating a potential upside of 109.06%. As a group, “Measuring & controlling devices, not elsewhere classified” companies have a potential upside of 27.28%. Given 908 Devices’ stronger consensus rating and higher possible upside, research analysts clearly believe 908 Devices is more favorable than its rivals.
Volatility and Risk
908 Devices has a beta of 1.59, meaning that its share price is 59% more volatile than the S&P 500. Comparatively, 908 Devices’ rivals have a beta of 1.03, meaning that their average share price is 3% more volatile than the S&P 500.
Earnings & Valuation
This table compares 908 Devices and its rivals gross revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| 908 Devices | $42.21 million | -$22.17 million | -16.31 |
| 908 Devices Competitors | $2.66 billion | $435.24 million | 11.09 |
908 Devices’ rivals have higher revenue and earnings than 908 Devices. 908 Devices is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Profitability
This table compares 908 Devices and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| 908 Devices | -56.68% | -15.20% | -12.07% |
| 908 Devices Competitors | -3,288.70% | 4.83% | 1.80% |
Institutional and Insider Ownership
79.2% of 908 Devices shares are owned by institutional investors. Comparatively, 61.0% of shares of all “Measuring & controlling devices, not elsewhere classified” companies are owned by institutional investors. 51.1% of 908 Devices shares are owned by insiders. Comparatively, 16.1% of shares of all “Measuring & controlling devices, not elsewhere classified” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
908 Devices beats its rivals on 7 of the 13 factors compared.
About 908 Devices (Get Rating)
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Receive News & Ratings for 908 Devices Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for 908 Devices and related companies with MarketBeat.com’s FREE daily email newsletter.